Scilex Holding Co - Common Stock, $0.0001 par value per share (SCLX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2022 to Q3 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
SCLX on Nasdaq
Shares outstanding
381,928,569
Price per share
$0.20
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
0
Total reported value
$0
Share change
-4,033
Value change
-$1,245
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Scilex Holding Co - Common Stock, $0.0001 par value per share (SCLX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SCLX Stock Acquisition JV LLC 21% -7.4% $16,117,386 -$805,874 80,586,928 -4.8% SCLX Stock Acquisition JV LLC 21 Jan 2025
ORAMED PHARMACEUTICALS INC. 9.9% +62% $146,543 -$2,953,457 732,717 -95% Oramed Pharmaceuticals Inc. 31 Mar 2025

As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Scilex Holding Co - Common Stock, $0.0001 par value per share (SCLX). This represents 0% of the company’s total 381,928,569 outstanding shares.

Institutional Holders of Scilex Holding Co - Common Stock, $0.0001 par value per share (SCLX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$1,245 $0.20 0
2025 Q2 3,046 $1,000 -$11,031,966 $0.33 1
2025 Q1 44,417,581 $11,036,421 -$1,415,906 $0.25 74
2024 Q4 49,074,470 $20,921,356 +$6,459,252 $0.43 95
2024 Q3 33,682,385 $31,141,750 -$6,561,251 $0.92 90
2024 Q2 39,828,625 $76,860,923 +$23,046,480 $1.93 86
2024 Q1 28,117,931 $44,707,915 +$2,718,622 $1.59 89
2023 Q4 26,161,758 $53,366,488 -$5,090,130 $2.04 88
2023 Q3 28,579,542 $40,008,144 +$8,153,213 $1.40 76
2023 Q2 21,006,804 $116,996,216 +$45,015,596 $5.57 87
2023 Q1 12,711,330 $104,208,444 +$103,518,322 $8.20 83
2022 Q4 5,205 $49,551 +$49,551 $9.52 1